Search Results - "Carobbio, A."

Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study by Tefferi, A, Rumi, E, Finazzi, G, Gisslinger, H, Vannucchi, A M, Rodeghiero, F, Randi, M L, Vaidya, R, Cazzola, M, Rambaldi, A, Gisslinger, B, Pieri, L, Ruggeri, M, Bertozzi, I, Sulai, N H, Casetti, I, Carobbio, A, Jeryczynski, G, Larson, D R, Müllauer, L, Pardanani, A, Thiele, J, Passamonti, F, Barbui, T

“…Under the auspices of an International Working Group, seven centers submitted diagnostic and follow-up information on 1545 patients with World Health…”
Get full text

PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics by Massi, D., Brusa, D., Merelli, B., Ciano, M., Audrito, V., Serra, S., Buonincontri, R., Baroni, G., Nassini, R., Minocci, D., Cattaneo, L., Tamborini, E., Carobbio, A., Rulli, E., Deaglio, S., Mandalà, M.

“…Programmed cell death ligand 1 (PD-L1) is a cell surface molecule that plays a critical role in suppressing immune responses, mainly through binding of the…”
Get full text

A multicenter validation of the revised version of the Milan system for reporting salivary gland cytology (MSRSGC) by Mazzola, F., Tomasoni, M., Mocellin, D., Dalè, M., Iandelli, A., Carobbio, A., Marchi, F., Filauro, M., Petruzzi, G., Massa, B., Facchetti, M., Battocchio, S., Marandino, F., Lombardi, D., Pichi, B., Pellini, R., Nicolai, P., Peretti, G.

“…•FNA cytology can obtain a precise insight of the salivary gland lumps.•The MSRSGC is a 6-tiered classification which estimates the risk of malignancy…”
Get full text

Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia by Barbui, T, Vannucchi, A M, Buxhofer-Ausch, V, De Stefano, V, Betti, S, Rambaldi, A, Rumi, E, Ruggeri, M, Rodeghiero, F, Randi, M L, Bertozzi, I, Gisslinger, H, Finazzi, G, Carobbio, A, Thiele, J, Passamonti, F, Falcone, C, Tefferi, A

Get full text

High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists by De Stefano, V, Ruggeri, M, Cervantes, F, Alvarez-Larrán, A, Iurlo, A, Randi, M L, Elli, E, Finazzi, M C, Finazzi, G, Zetterberg, E, Vianelli, N, Gaidano, G, Rossi, E, Betti, S, Nichele, I, Cattaneo, D, Palova, M, Ellis, M H, Cacciola, R, Tieghi, A, Hernandez-Boluda, J C, Pungolino, E, Specchia, G, Rapezzi, D, Forcina, A, Musolino, C, Carobbio, A, Griesshammer, M, Sant’Antonio, E, Vannucchi, A M, Barbui, T

“…The optimal duration of treatment with vitamin K antagonists (VKA) after venous thromboembolism (VTE) in patients with Philadelphia-negative myeloproliferative…”
Get full text

Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria by Finazzi, G, Carobbio, A, Thiele, J, Passamonti, F, Rumi, E, Ruggeri, M, Rodeghiero, F, Randi, M L, Bertozzi, I, Vannucchi, A M, Antonioli, E, Gisslinger, H, Buxhofer-Ausch, V, Gangat, N, Rambaldi, A, Tefferi, A, Barbui, T

“…In an international study of 1104 patients with essential thrombocythemia (ET), a histological review according to the 2008 World Health Organization (WHO)…”
Get full text

Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients by De Stefano, V, Vannucchi, A M, Ruggeri, M, Cervantes, F, Alvarez-Larrán, A, Iurlo, A, Randi, M L, Pieri, L, Rossi, E, Guglielmelli, P, Betti, S, Elli, E, Finazzi, M C, Finazzi, G, Zetterberg, E, Vianelli, N, Gaidano, G, Nichele, I, Cattaneo, D, Palova, M, Ellis, M H, Cacciola, E, Tieghi, A, Hernandez-Boluda, J C, Pungolino, E, Specchia, G, Rapezzi, D, Forcina, A, Musolino, C, Carobbio, A, Griesshammer, M, Barbui, T

“…We retrospectively studied 181 patients with polycythaemia vera ( n =67), essential thrombocythaemia ( n =67) or primary myelofibrosis ( n =47), who presented…”
Get full text

Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts by CAPELLI, C, DOMENGHINI, M, BORLERI, G, BELLAVITA, P, POMA, R, CAROBBIO, A, MICO, C, RAMBALDI, A, GOLAY, J, INTRONA, M

“…We compared two protocols for the expansion of human mesenchymal stromal cells (hMSCs) starting from diagnostic samples of BM aspirates (2-5 ml) or using the…”
Get full text

The histone deacetylase inhibitor ITF2357 selectively targets cells bearing mutated JAK2 by Guerini, V, Barbui, V, Spinelli, O, Salvi, A, Dellacasa, C, Carobbio, A, Introna, M, Barbui, T, Golay, J, Rambaldi, A

“…We investigated the activity of ITF2357, a novel histone deacetylase inhibitor (HDACi) with antitumor activity, on cells carrying the JAK2(V617F) mutation…”
Get full text

How reliable is assessment of true vocal cord-arytenoid unit mobility in patients affected by laryngeal cancer? a multi-institutional study on 366 patients from the ARYFIX collaborative group by Ferrari, M., Mularoni, F., Taboni, S., Crosetti, E., Pessina, C., Carobbio, A.L.C., Montalto, N., Marchi, F., Vural, A., Paderno, A., Caprioli, S., Gaudioso, P., Fermi, M., Rigoni, F., Saccardo, T., Contro, G., Ruaro, A., Lo Manto, A., Varago, C., Baldovin, M., Bandolin, L., Filauro, M., Sampieri, C., Missale, F., Ioppi, A., Carta, F., Ramanzin, M., Ravanelli, M., Maiolo, V., Bertotto, I., Del Bon, F., Lancini, D., Mariani, C., Marrosu, V., Tatti, M., Cağlı, S., Yüce, I., Gündoğ, M., Dogan, S., Anile, G., Gottardi, C., Busato, F., Vallin, A., Gennarini, F., Bossi, P., Ghi, M.G., Lionello, M., Zanoletti, E., Marioni, G., Maroldi, R., Mattioli, F., Puxeddu, R., Bertolin, A., Presutti, L., Piazza, C., Succo, G., Peretti, G., Nicolai, P.

“…•In laryngeal oncology it is crucial to assess mobility of vocal cord-arytenoid unit.•Current mobility assessment is flawed by weak inter-observer…”
Get full text

Elevated C-reactive protein is associated with shortened leukemia-free survival in patients with myelofibrosis by Barbui, T, Carobbio, A, Finazzi, G, Guglielmelli, P, Salmoiraghi, S, Rosti, V, Rambaldi, A, Vannucchi, A M, Barosi, G

Get full text

Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3 by BARBUI, Tiziano, CAROBBIO, Alessandra, OTTOMANO, Cosimo, MARCHIOLI, Roberto, CUCCOVILLO, Ivan, BOTTAZZI, Barbara, MANTOVANI, Alberto, RAMBAIDI, Alessandro, FINAZZI, Guido, VANNUCCHI, Alessandro M, BAROSI, Giovanni, ANTONIOLI, Elisabetta, GUGLIELMELLI, Paola, PANCRAZZI, Alessandro, SALMOIRAGHI, Silvia, ZILIO, Pio

“…We tested the hypothesis that levels of pentraxin high sensitivity C-reactive protein and pentraxin 3 might be correlated with cardiovascular complications in…”
Get full text

CALR mutation, MPL mutation and triple negativity identify patients with the lowest vascular risk in primary myelofibrosis by Finazzi, M C, Carobbio, A, Cervantes, F, Isola, I M, Vannucchi, A M, Guglielmelli, P, Rambaldi, A, Finazzi, G, Barosi, G, Barbui, T

Get full text

The rate of transformation from JAK2-mutated ET to PV is influenced by an accurate WHO-defined clinico-morphological diagnosis by Barbui, T, Thiele, J, Carobbio, A, Vannucchi, A M, Tefferi, A

Get full text

SP-012: Image guided minimally invasive and robotic techniques for sinus and base of skull malignancies by Nicolai, P, Bolzoni Villaret, A, Schreiber, A, Carobbio, A

Get full text

The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600 by Massi, D., Brusa, D., Merelli, B., Falcone, C., Xue, G., Carobbio, A., Nassini, R., Baroni, G., Tamborini, E., Cattaneo, L., Audrito, V., Deaglio, S., Mandalà, M.

“…BRAF inhibitors (BRAFi) improve survival in metastatic melanoma patients (MMP) but the duration of clinical benefit is limited by development of drug…”
Get full text

Essential thrombocythemia with high hemoglobin levels according to the revised WHO classification by Barbui, T, Thiele, J, Kvasnicka, H M, Carobbio, A, Vannucchi, A M, Tefferi, A

Get full text

Full‐Right‐Full‐Left Split Liver Transplantation: The Retrospective Analysis of an Early Multicenter Experience Including Graft Sharing by Zambelli, M., Andorno, E., De Carlis, L., Rossi, G., Cillo, U., De Feo, T., Carobbio, A., Giacomoni, A., Bottino, G., Colledan, M.

“…Full‐right‐full‐left split liver transplantation divides a donor liver into two grafts to be transplanted in adult‐size patients. Major technical and…”
Get full text

P1009: PREDICTORS OF HOSPITALIZATION AND SEVERE OUTCOMES IN PATIENTS WITH MPN AND COVID‐19 by Barbui, T., Carobbio, A., Masciulli, A., Iurlo, A., Sobas, M. A., Elli, E. M., Rumi, E., De Stefano, V., Lunghi, F., Marchetti, M., Daffini, R., Gasior Kabat, M., Cuevas, B., Fox, M. L., Andrade Campos, M. M., Palandri, F., Guglielmelli, P., Benevolo, G., Harrison, C., Foncillas, M. A., Bonifacio, M., Alvarez‐Larran, A., Kiladjian, J.‐J., Bolanos Calderon, E., Patriarca, A., Quiroz Cervantes, K. S., Griesshammer, M., Garcia‐Gutierrez, V., Marin Sanchez, A., Magro Mazo, E., Ruggeri, M., Hernandez‐Boluda, J. C., Osorio, S., Carreno‐Tarragona, G., Sagues Serrano, M., Kusec, R., Navas Elorza, B., Angona, A., Xicoy Cirici, B., Lopez Abadia, E., Koschmieder, S., Cichocka, E., Kulikowska de Nałęcz, A., Bellini, M., Cattaneo, D., Bucelli, C., Cavalca, F., Borsani, O., Betti, S., Curto‐Garcia, N., Carbonell, S., Benajiba, L., Rambaldi, A., Vannucchi, A. M.

Get full text

Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients by Rambaldi, A, Bacigalupo, A, Fanin, R, Ciceri, F, Bonifazi, F, Falda, M, Lambertenghi-Deliliers, G, Benedetti, F, Bruno, B, Corradini, P, Alessandrino, P E, Iacopino, P, Arcese, W, Scimè, R, Raimondi, R, Sica, S, Castagna, L, Lamparelli, T, Oneto, R, Lombardini, L, Pollichieni, S, Algarotti, A, Carobbio, A, Sacchi, N, Bosi, A

“…An unrelated donor (UD) search was submitted to the Italian Bone Marrow Donor Registry between February 2002 and December 2004, for 326 consecutive patients…”
Get full text